Inhibitors of Akt activity

The present invention is directed to compounds which contain substituted naphthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer...

Full description

Saved in:
Bibliographic Details
Main Authors Arruda, Jeannie M, Campbell, Brian T, Cosford, Nicholas D. P, Hoffman, Jacob M, Hu, Essa H, Layton, Mark E, Li, Yiwei, Liang, Jun, Rodzinak, Kevin J, Siu, Tony, Stearns, Brian A, Tehrani, Lida R, Bilodeau, Mark T, Manley, Peter J
Format Patent
LanguageEnglish
Published 22.03.2011
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to compounds which contain substituted naphthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention. These substituted naphthyridines have unexpected advantageous properties when compared to other naphthyridines reported in PCT publication WO2003/086394, such unexpected advantageous properties may include increased cellular potency/solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity and so on.